Breaking News Instant updates and real-time market news.

PTGX

Protagonist Therapeutics

$9.49

2.47 (35.19%)

12:56
08/06/18
08/06
12:56
08/06/18
12:56

Protagonist price target raised to $21 after study re-analysis at Leerink

Leerink analyst Joseph P. Schwartz raised his price target on Protagonist Therapeutics shares to $21 from $13 after the company announced results from an independent blinded re-analysis of the Phase 2 PROPEL study of oral alpha-4-beta-7 integrin antagonist PTG-100 for the treatment of patients with ulcerative colitis. He maintains an Outperform rating on Protagonist shares.

  • 06

    Aug

PTGX Protagonist Therapeutics
$9.49

2.47 (35.19%)

06/06/18
LEHM
06/06/18
DOWNGRADE
Target $8.5
LEHM
Equal Weight
Protagonist downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Protagonist Therapeutics to Equal Weight and lowered his price target for the shares to $8.50 from $30. The analyst continues to see value in the company's pipeline assets, but does expect achievement of key catalysts until the second half of 2019. As such, the analyst sees greater near-term potential in small cap names with catalysts upcoming, such as Foamix (FOMX).
03/27/18
BMOC
03/27/18
NO CHANGE
Target $13
BMOC
Outperform
Protagonist Therapeutics price target lowered to $13 from $42 at BMO Capital
BMO Capital analyst M. Ian Somaiya slashed his price target on Protagonist Therapeutics (PTGX) to $13 following the announcement that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis. Somaiya adds that his valuation is now driven by the risk-adjusted sales model for PTG-200, which "represents a higher probability clinical program with peak sales of over $2B". The analyst also notes that he continues to exclude the clinical data of PTG-300 from his model. Despite the steep price target revision, Somaiya keeps his Outperform rating and recommends that investors buy into the weakness after the PTG-100 clinical disappointment on anticipated PTG-200 data and the advancement of Johnson&Johnson (JNJ) - shared Stelara.
03/26/18
STFL
03/26/18
DOWNGRADE
Target $11
STFL
Hold
Protagonist Therapeutics downgraded to Hold from Buy at Stifel
Stifel analyst Adam Walsh downgraded Protagonist Therapeutics to Hold and cut his price target for the shares to $11 from $32. The downgrade follows news that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis.
01/29/18
STFL
01/29/18
INITIATION
Target $32
STFL
Buy
Protagonist Therapeutics initiated with a Buy at Stifel
Stifel analyst Adam Walsh started Protagonist Therapeutics with a Buy rating and $32 price target, saying he sees a relatively low hurdle for success for its near-term interim Phase 2b results for PTG-100 in moderate-to-severe ulcerative colitis. Protagonist appears poised for upside given the company's three unique pipeline assets in the clinic targeting market opportunities of over $1B, added Walsh.

TODAY'S FREE FLY STORIES

ARE

Alexandria Real Estate

$139.70

-0.43 (-0.31%)

17:09
03/19/19
03/19
17:09
03/19/19
17:09
Hot Stocks
Alexandria Real Estate co-CEO sells 3,721 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

XXII

22nd Century

$1.94

0.02 (1.04%)

17:02
03/19/19
03/19
17:02
03/19/19
17:02
Hot Stocks
BlackRock reports 6.5% passive stake in 22nd Century »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$98.72

0.95 (0.97%)

17:00
03/19/19
03/19
17:00
03/19/19
17:00
Initiation
Zoetis initiated  »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDM

Piedmont Office Realty

$20.21

-0.27 (-1.32%)

16:59
03/19/19
03/19
16:59
03/19/19
16:59
Hot Stocks
Piedmont Office Realty CEO Miller to retire, Brent smith to succeed »

Piedmont Office Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 15

    May

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Initiation
Teva initiated  »

Teva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FLIC

First Long Island

$22.35

-0.52 (-2.27%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Hot Stocks
First Long Island selects Christopher Becker to succeed Michael Vittorio as CEO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:51
03/19/19
03/19
16:51
03/19/19
16:51
Hot Stocks
Steelcase boosts quarterly dividend 7% to 14.5c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

PRGO

Perrigo

$49.20

0.52 (1.07%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Initiation
Perrigo initiated at SunTrust »

Perrigo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMK

Trustmark

$34.42

-0.7 (-1.99%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Downgrade
Trustmark rating change at Keefe Bruyette »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WIX

Wix.com

$108.92

1.02 (0.95%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Initiation
Wix.com initiated at Guggenheim »

Wix.com initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$19.00

-0.23 (-1.20%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Hot Stocks
Carlyle Group appoints Christopher Finn COO »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Syndicate
Invitation Homes files to sell 43M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Earnings
Steelcase sees FY20 EPS $1.20-$1.35, consensus $1.32 »

Sees FY20 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

16:48
03/19/19
03/19
16:48
03/19/19
16:48
Periodicals
Boeing CEO says understands 'lives depend' on jet safety, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:47
03/19/19
03/19
16:47
03/19/19
16:47
Earnings
Steelcase sees Q1 EPS 16c-20c, consensus 20c »

Sees Q1 revenue $830 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

EOLS

Evolus

, AGN

Allergan

$154.13

3.41 (2.26%)

16:46
03/19/19
03/19
16:46
03/19/19
16:46
Initiation
Evolus, Allergan initiated at SunTrust »

Evolus assumed with a Buy…

EOLS

Evolus

AGN

Allergan

$154.13

3.41 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

NVCR

Novocure

$50.99

-0.11 (-0.22%)

16:45
03/19/19
03/19
16:45
03/19/19
16:45
Initiation
Novocure initiated at SunTrust »

Novocure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated at SunTrust »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated at Guggenheim »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated at SunTrust »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated at SunTrust »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.